News | October 07, 2009

Incidental Findings in Cardiac CT Rarely Significant


October 7, 2009 – Rates of death were similar in patients with and without incidental findings (IF) identified with cardiac computed tomography (CT), and IF was not an independent predictor of noncardiac death, reported researchers in a study published in the online version of the October 2009 issues of the Journal of the American College of Cardiology.

As cardiac CT becomes more widely adopted, prompting the discovery of extracardiac IF to potentially increase, researchers in the study, Potential Clinical and Economic Consequences of Noncardiac Incidental Findings on Cardiac Computed Tomography, set out to determine “the incidence, clinical significance, and potential financial impact of noncardiac IF identified with cardiac computed tomography (CT).”

Of 966 patients (58 ± 16 years of age, 55.4 percent men, >98 percent outpatients), who underwent cardiac CT and had noncardiac structures evaluated after full field of view (32 to 50 cm) reconstruction, 401 (41.5 percent) patients had noncardiac IF. A total of 12 (1.2 percent) patients had clinically significant (CS) findings, and 68 (7.0 percent) patients had indeterminate findings. At follow-up (18.4 ± 7.6 months), none of the indeterminate findings became CS. After adjusting for age, IF were not an independent predictor of noncardiac death. Noncardiac death and cancer death in patients with and without IF were not statistically different. One patient suffered a major complication related to the investigation of an IF. The total direct cost associated with investigating IF was Canadian $57,596 (U.S. $83,035).

Based on their findings, the researchers concluded: “Although noncardiac IF are common, clinically significant or indeterminate IF are less prevalent. Rates of death were similar in patients with and without IF, and IF was not an independent predictor of noncardiac death. The investigation of IF is not without cost or risk. Larger studies are required to assess the potential mortality benefit of identifying IF.”

References: JMacHaalany, M.D., Jimmy, et al. Potential Clinical and Economic Consequences of Noncardiac Incidental Findings on Cardiac Computed Tomography. J Am Coll Cardiol, 2009; 54:1533-1541, doi:10.1016/j.jacc.2009.06.026.

For more information: http://content.onlinejacc.org/cgi/content/abstract/54/16/1533


Related Content

News | Computed Tomography (CT)

July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

Home July 16, 2024
Home
News | Computed Tomography (CT)

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

Home May 01, 2024
Home
News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
Subscribe Now